We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$2.4B
Cap. Flow
+$2.12B
Cap. Flow %
1.78%
Top 10 Hldgs %
24.78%
Holding
3,988
New
162
Increased
1,714
Reduced
1,756
Closed
200

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$99.6M
2
AAPL icon
Apple
AAPL
+$88.3M
3
MBB icon
iShares MBS ETF
MBB
+$85.4M
4
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$51.6M
5
CSCO icon
Cisco
CSCO
+$43.2M

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Financials 8.89%
3 Healthcare 8.4%
4 Industrials 6.56%
5 Consumer Discretionary 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
3751
Alaunos Therapeutics
TCRT
$4.81M
$3.59K ﹤0.01%
182
-226
-55% -$9.74K
MDNA
3752
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$3.07K ﹤0.01%
10,400
FRBK
3753
DELISTED
Republic First Bancorp Inc
FRBK
$2.9K ﹤0.01%
15,250
-13,500
-47% -$11.2K
FAZE
3754
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2.37K ﹤0.01%
14,311
MCLD
3755
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
$1.39K ﹤0.01%
12,477
-13,200
-51% -$4.33K
POL
3756
DELISTED
Polished.com Inc.
POL
$1.28K ﹤0.01%
316
AMRS
3757
DELISTED
Amyris Inc.
AMRS
$890 ﹤0.01%
14,827
-19,236
-56% -$14.3K
NOGNW
3758
DELISTED
Nogin, Inc. Warrant
NOGNW
$284 ﹤0.01%
14,287
BODY.WS
3759
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$213 ﹤0.01%
11,199
AAPL icon
3760
CALL
Apple
AAPL
$4.45T
-1,000
Closed -$180K
ABG icon
3761
Asbury Automotive
ABG
$3.73B
-1,391
Closed -$334K
AGS
3762
DELISTED
PlayAGS
AGS
-11,298
Closed -$63.8K
AIR icon
3763
AAR Corp
AIR
$5.86B
-3,523
Closed -$203K
AMC icon
3764
AMC Entertainment Holdings
AMC
$2.14B
-1,125
Closed -$49.5K
AMED
3765
DELISTED
Amedisys
AMED
-5,780
Closed -$529K
AMGN icon
3766
CALL
Amgen
AMGN
$224B
-8,500
Closed -$1.87M
AMKR icon
3767
Amkor Technology
AMKR
$13.5B
-70,949
Closed -$2.11M
AMZN icon
3768
CALL
Amazon
AMZN
$2.94T
-4,000
Closed -$380K
ANET icon
3769
PUT
Arista Networks
ANET
$250B
-4,800
Closed -$186K
ANGO icon
3770
AngioDynamics
ANGO
$651M
-20,111
Closed -$210K
ASIX icon
3771
AdvanSix
ASIX
$452M
-51,572
Closed -$1.8M
ATXS
3772
DELISTED
Astria Therapeutics
ATXS
-12,308
Closed -$103K
AXDX
3773
DELISTED
Accelerate Diagnostics
AXDX
-1,700
Closed -$13.8K
FABC
3774
Fabric.AI Inc
FABC
$18.4M
-127
Closed -$11.2K
AZUL
3775
DELISTED
Azul
AZUL
-31,000
Closed -$424K

Similar funds

Raymond James & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Raymond James & Associates held 3,988 positions worth $119B, down 2% from $121B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q3 2023 filing shows 162 new, 1,714 increased, 1,756 reduced and 200 closed positions. Its largest new stake was InterContinental Hotels: 102,555 shares worth $7.67M. The largest sale was RTX Corp, an estimated $99.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2023 buy was InterContinental Hotels: 102,555 shares worth $7.67M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2023, an estimated $630M increase.
  • Raymond James & Associates's biggest Q3 2023 reduction was RTX Corp, cutting an estimated $99.6M.
  • Raymond James & Associates fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $17.3M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $119B portfolio in Q3 2023.
  • Raymond James & Associates opened 162 new positions and closed 200 in Q3 2023.
  • Raymond James & Associates's portfolio value fell 2% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.